InternationalUSRemember you can easily switch between MIP US and MIP International at any time

International Patent Forum - Speakers

10 & 11 March, 2015 - The Waldorf Hilton Hotel


Baroness Neville-Rolfe DBE CMG
Baroness Neville-Rolfe

Parliamentary Under Secretary of State for Intellectual Property
Department for Business, Innovation & Skills

Baroness Neville-Rolfe is the Minster responsible for UK national intellectual property strategy and for the Intellectual Property Office (IPO). The IPO is the official government body responsible for intellectual property (IP) rights in patents, designs trade marks and copyright, and for legislation and coordination of IP enforcement.

In addition to IP, Baroness Neville-Rolfe is responsible for the work of the Department for Business, Innovation and Skills in the House of Lords. This includes innovation policy, industrial strategies, business regulation and consumer protection.

Baroness Neville-Rolfe also has responsibility for coordinating EU engagement across all policy areas of the Department for Business, Innovation and Skills, and is co-chair of the Professional and Business Services (PBS) Council.

Baroness Neville-Rolfe previously sat on the boards of several major businesses, including serving as a non-executive director of ITV plc and of 2 Sisters Food Group, a large privately owned UK food producer, as a member of the supervisory board of Metro Group, a large German-based international retailer and wholesaler, and on PWC's advisory Board. She recently served as President of EuroCommerce, the pan-European retail and wholesale trade association. She is a member of the London Business School's Governing Body.

Patrick Kilbride
Patrick Kilbride

Executive Director for International Intellectual Property, Global Intellectual Property Center
U.S. Chamber of Commerce


Patrick Kilbride is executive director of international intellectual property for the Global Intellectual Property Center (GIPC) at the U.S. Chamber of Commerce. There, he oversees the center's multilateral and international programs promoting the protection and enforcement of intellectual property (IP) rights, managing a team of country and regional experts. Previously, Kilbride was Executive Director, Americas Strategic Policy Initiatives, and Executive Vice President, Association of American Chambers of Commerce in Latin America (AACCLA), within the Chamber's International Division.

Prior to joining the U.S. Chamber, Kilbride was appointed to serve in the Bush administration as deputy assistant U.S. Trade Representative (USTR) for
Intergovernmental Affairs & Public Liaison. At USTR, Kilbride worked with state and local officials, business organizations, and non-governmental organizations to advance the President's trade policy agenda; he served as USTR liaison to the network of industry trade advisory committees (ITACs), as well as the President's Export Council; and, he was part of a White House-led, inter-agency team that coordinated efforts to secure congressional approval of pending U.S. free trade agreements.

Previously, Kilbride was director of Government Affairs at the Council of the Americas, where he played leading roles in industry coalition efforts that saw the network of U.S. free trade partners in the Americas expand from two countries to twelve in less than a decade.

At the American Apparel & Footwear Association, Kilbride represented U.S. apparel manufacturers as government relations representative, helping to secure enactment of the Caribbean Basin Trade Partnership and African Growth and Opportunity Acts. Kilbride began his career in global economic policy as an international trade
specialist with the law firm of LeBoeuf, Lamb, Greene & MacRae.

Clemens Heusch

Head of European litigation

Dr. Clemens-August Heusch, LL.M. is Head of European Litigation at Nokia where he is responsible for litigation and arbitration throughout Europe with a strong focus on German and UK IP litigation. Before joining Nokia, Clemens worked for more than four years (2004-2008) as attorney at-law at the international law firm Bird & Bird LLP.

Clemens studied law at the Universities of Freiburg and Bonn, Germany. He received a LL.M. degree from the University of Maastricht, Netherlands and a doctorate degree from the University of Cologne, Germany. During his traineeship, he worked inter alia in the competition law team of Freshfields Bruckhaus Deringer in Cologne and Brussels, Belgium.

Clemens is registered lawyer at the Cologne Bar and holds the title of a certified IP lawyer. He regularly gives legal presentations and publishes legal articles. He is fluent in German, English and French.

Julie Dunnett

Director of Intellectual Property
GKN plc

Julie has been in the patent profession for over 30 years - initially in private practice, both in firms of Patent Attorneys and in the IP department of a UK general law firm. 

In 1995 she transferred to an in-house role in Ford Motor Company where she worked in the European IP Department based in Brentwood. The Ford role involved drafting and negotiating numerous agreements relating to R & D and to trade marks. She was also responsible for the IP aspects of a number of acquisitions, notably the acquisition of Volvo Cars from AB Volvo. As a result of this acquisition Julie moved to Sweden for 6 months to help to set up a Volvo Cars IP Department and to develop with AB Volvo the management processes for the VOLVO trade mark.

Julie has been with GKN since 2003 working within the Corporate Centre for the group as a whole and for each of its 4 divisions. Her key responsibility is the Group's IP Strategy - its development and implementation throughout the business and communicating what this means to each of the divisions.

Kevin Fournier


Kevin is with IBM for over 18 years and provides legal advice and counsel on intellectual property issues. He advises in transactions such as technology joint research and development projects, joint ventures, business consulting, applications maintenance and development, strategic outsourcing, mergers and acquisitions, software licensing, patent licensing, and IP assignments.

Prior to joining IBM, Kevin worked as a private practitioner in Washington DC and Boston.

Gabriel Cuonzo
Gabriel Cuonzo
Trevisan & Cuonzo

Gabriel Cuonzo is co-founder of Trevisan & Cuonzo Avvocati and he is one of the most well known and reputed Italian lawyers on an international level. With over 30 years courtroom experience, Gabriel has represented many multinational companies before the Italian courts in a large number of high profile cases with an international dimension such as Scott v. Kaysersberg (1994), Fujitsu v. Samsung (1997), Rambus v. Micron (2000), TRW v. Koyo (2006), Pronovo v. Chiesi (2006), Ciba Vision v. Johnson & Johnson (2007), Angiotech v. Conor (2007), Novartis v. Actavis (2008), Unilever v. Nestlè (2008), Novartis v. Teva (2009), Astrazeneca v. Teva (2011), Biotec v. Novamont (2012). 

Gabriel is an experienced commercial lawyer often involved in complex, mostly IP driven, international transactions.  Gabriel is widely regarded as a leading figure in pharmaceutical litigation and regulatory.

Adrian Gregory

Tax Director

Adeline-Fleur Smith

senior patent attorney

Leonid Kravets

patent counsel
InterDigital Communications

Lenny is a IP attorney focusing on corporate development and strategy at InterDigital, Inc. His primary responsibilities include evaluation and analysis of strategic acquisition opportunities, with a particular focus on patents. Prior to coming to InterDigital, he practiced as an attorney with the law firm of Panitch, Schwarze, Belisario & Nadel in Philadelphia, PA. While at Panitch, his practice focused on patent prosecution and intellectual property transactional law, with a particular focus on advising emerging growth companies and entrepreneurs.
Lenny is a contributor of IP articles to the popular technology blog TechCrunch, and an adjunct professor at the Drexel University Earle Mack School of Law. He is a member of the bars of the states of New Jersey and Pennsylvania. He received his JD cum laude from the Temple University Beasley School of Law, and holds dual bachelors degrees in Computer Engineering and Electrical Engineering from Johns Hopkins University.

Adam Pilcher

patent manager
Metaswitch Networks

Adam manages Metaswitch's patent portfolio, with an emphasis on driving organic growth of the portfolio through training and support for inventors within the company. He acts as the main contact point internally for patent issues, and manages interactions with external counsel.

Alexander Herget

brand protection specialist

Alexander has worked extensively implementing brand protection strategies for German and International clients. He has been responsible for setting up online monitoring systems and database tracking systems. The key function of his role is to look at the global counterfeit issue and find ways to help track, trace and implement solutions for companies of all sizes with their varied and personal issues. He works closely with law enforcement bodies and uses his language and international knowledge to his advantage.

Simone Ferrara

patent attorney, Vodafone; council member, CIPA


Simone is a Global IPR Counsel at Vodafone in charge of building and managing a large portion of Vodafone global patent portfolio related in particular to communication networks & standards, machine to machine (M2M) technology and architecture, network security, rich communication services and future technologies.  He also advises the business on IPR contractual and strategic matters related to products, services and projects.

Simone acts as the lead IPR counsel for Cobra Automotive Technologies - a Vodafone company operating in the automotive and telematics sectors - as well as lead IPR counsel for projects related to public tenders and M2M programmes.  In addition, he is responsible for innovation generated in Vodafone Espana and Vodafone Italia.

Simone is a Chartered and European Patent Attorney, member of CIPA Council and Chair of the newly established Education & Professional Standards Committee at CIPA.

Charles Jeffries

Senior Patent Counsel

Charles Jeffries joined the Group Litigation and Intellectual Property team in Novartis International AG in July 2014 where he is Senior Patent Counsel. In this role, Charles is part of an expert IP policy team dedicated to addressing global IP policy issues that affect all of the divisions of Novartis, including both its innovator and generic divisions. As part of the Novartis IP policy team, he is also instrumental in defining and advocating Novartis' position on IP policy matters.
Prior to his current role, Charles was responsible for the management of IP for the Pharmaceuticals division of Novartis in Africa, Middle East and Asia Pacific countries and, prior to that, Charles led a global patent team focussing on worldwide patent prosecution, patent filing strategy and patent portfolio management. Charles has also managed several worldwide patent litigations and has experience particularly in European
patent litigation.

Charles started his career in private practice in the UK and then, in 2006, moved over to work as an in-house attorney for Novartis in Switzerland. Charles is a registered European Patent Attorney, a Chartered Patent Attorney (UK) and a registered Swiss Patent Attorney. Charles holds a Masters degree in Medicinal Chemistry from the University of Leeds, UK and a Master's degree in Management of Intellectual Property Law from Queen Mary College London, UK.

Réda Bouchenak

European Patent Attorney

Gavin Clarke

VP, IP Licensing EMEA
Rovi Corporation


Andrew Hammond

senior partner

Andrew Hammond is a founding partner of Valea AB and a European Patent Attorney. He has a degree in mechanical engineering and has been working in the IP field since 1983, initially as an Examiner at the European Patent Office and since 1990 in private practice in Sweden. Most of his time is spent in post-grant patent proceedings. He is frequently in Munich representing clients before Opposition Divisions and the Boards of Appeal of the European Patent Office. He is also heavily involved in several global litigation cases. Andrew is a CEIPI-tutor and regularly holds lectures and seminars on all aspects of European patent procedures.

Maria Engstrand

senior partner

Maria has expertise within the areas of mechanics, physics and medical devices. She has special experience with freedom-to-use analyses, validity and infringement evaluations, and European opposition proceedings. Prior to joining Valea in January 2004, Maria worked for six years as an IPR consultant for Awapatent and before that she worked with Siemens Elema AB.
Maria has worked as a patent attorney and IPR consultant since 1997.

Russell Bagnall

Adams & Adams

Russell Bagnall has been a partner at Adams & Adams since 1998. Prior to joining Adams & Adams in 1994 he spent several years employed by a multinational mining house including a period in the R&D department.

Russell specialises in patent litigation and opinion work, mainly in the field of pharmaceuticals and chemistry. He has advised clients on several contentious issues involving pharmaceutical disputes between multi-national and generic companies. He also advises pharmaceutical clients on a wider range of issues including licence and distribution agreements, co-promotion agreements and regulatory issues. Russell is also responsible for managing multi-jurisdictional litigation in several African countries.

He is the head of the Patent and Design litigation group. Russell has been internationally recognised in peer-selected reviews such as the International Who's Who of Patent Lawyers and the International Who's Who of Life sciences Lawyers. Russell was also ranked in tier 1 for patent litigation in South Africa by IAM 250-The World's Leading Patent Litigators (2011 to 2013).

Adams & Adams has been rated in the top tier several times for patent litigation by Managing Intellectual Property and was voted as the South African law firm of the year by MIP in 2011 and 2012.

Russell is an active member of the South African group of AIPPI and is also a member of FICPI. He is also a fellow of the South African Institute of Intellectual Property Law and is the convenor of the Patent Law Committee which engages government on legislative issues on behalf of its members.

Dario Tanziani

Adams & Adams

Dario has 28 years experience and has represented a variety of multinational research based pharmaceutical companies with blockbuster drug patent litigation. Dario’s practice includes patent searches, transactional matters and prosecution of new patent filings. He has also contributed on aspects of South African and African patent law in several books and professional periodicals.

Selin Sinem Erciyas

Gün + Partners

Selin Sinem Erciyas is a partner with Gün & Partners in the Intellectual Property Department, and specializing in Patent Law and Life Sciences issues.

Selin has been involved in a number of advisory and litigation matters in all fields of IP and has handled hundreds of both contentious and non-contentious administrative oppositions and court actions involving patents and trademarks. Selin took responsibility in a number of patent infringement actions, declaration of non-infringement actions and nullity actions.
Within the Pharmaceutical IP practice, Selin has conducted several researches on TRIPS, TBR, and EU Directives on licensing of pharmaceuticals and their administrative reflection to Turkish legislations and regulations.

Selin represents number of multinational pharmaceutical companies before the Ministry of Health in relation to regulatory issues and assisted these pharmaceutical companies in regulatory examinations before the MOH.
Selin specialized in the regulatory aspects of the nutrients for special nutrition, diet nutrients for medical purposes, baby and infant additional (extra) nutrients, formula feeding, infant food and herbal products. She took responsibility in handling the legal and regulatory issues in transferring of the Medical Nutrition Department of a multinational pharmaceutical company to another multinational pharmaceutical and Nutrition Company.

Selin also serves as a counsel to the Association of Research-Based Pharmaceutical Companies (AIFD). She represented the AIFD at the commission meetings of the Turkish Parliament on the draft Patent Law in Turkey. She prepared a number of position papers for the attention of the parliament, especially reflecting the comparison of the draft patent law with the international agreements and associations.

Özge Atilgan Karakulak

Gün + Partners

Özge Atilgan Karakulak is a partner with the law firm of Mehmet Gün & Partners which is internationally renowned for its expertise among others in intellectual property, and Turkish commercial and corporate law. Her practice focuses on patent rights, life sciences, antitrust and public procurement.

Özge has been involved in and has led many patent infringement actions against generic pharmaceutical companies and initiated with Mehmet Gün the first ever pharmaceutical data protection and exclusivity actions in Turkey. She combines her IP litigation expertise with her extensive knowledge of life science sectors. She advises a number of multinational life science companies on a wide range of matters including registration procedures, promotion practices, pricing and reimbursement regulations, distribution relationships and co-marketing deals, as well as on issues of merger control, vertical restraints and abusive conduct. She advised and represented a multinational pharmaceutical company in negotiating a contract with the Turkish Ministry of Health for the supply of H1N1 influenza vaccine.

She serves as a counsel to the Association of Research-Based Pharmaceutical Companies and the Association of Research-Based Medical Technologies Manufacturers in Turkey, and advises on many IP and regulatory policy papers and drafting laws and regulations proposed to the Turkish governmental authorities.

Denis V. Keseris
Denis V. Keseris
Senior Associate
Withers & Rogers

Denis is a European and UK Patent Attorney at Withers & Rogers and represents clients involved in a wide range of technologies, with a particular focus on telecom standards (both long-haul fibre optic communications and wireless data communications) and semiconductor electronics. Denis was previously in-house at the IP department of Bell Labs, where he was involved in a range of activities relating to the creation and use of standard-essential patent rights in Europe and overseas. 

Denia has also participated in the preparation of patent submissions to standards bodies and has acted as a patent essentiality evaluator for a large standards licensing entity. Denis has worked with a wide range of clients in Europe, the UK and Asia; from private inventors and small start-ups looking to attract investment, to large multinational clients wanting to strengthen their existing portfolios and assert their rights through litigation and licensing.

Keith Gilman

Lerner David Littenberg Krumholz & Mentlik

Keith E. Gilman, a partner in the firm, is involved in all facets of the IP practice. He counsels clients on maximizing the value of their IP assets and advises clients on the IP risks associated with new product designs and acquisitions with an emphasis in mechanical devices. Tapping his extensive background in litigation, licensing and due diligence, Mr. Gilman emphasizes the importance of building strategies to protect clients' innovations and trademarks, while minimizing the risk of litigation by competitors. Mr. Gilman recognizes that efforts to manage risk can be used as opportunities to establish IP assets that create advantages in the marketplace.

Mr. Gilman regularly conducts substantive due diligence activities in connection with the license or purchase of technologies and product lines. These activities focus on helping establish a value for the target company or technology, and are useful in structuring, negotiating and drafting the deal. Mr. Gilman also has considerable experience in assisting clients with the effective integration of the acquired technologies so that the client realizes the value previously forecasted.

Timothy May


Timothy May is a partner in Finnegan, Henderson, Farabow, Garrett & Dunner, LLP’s Washington, DC office. He has over 20 years of experience in the field of U.S. patent law. He practices patent litigation, patent prosecution, and counseling on IP management matters. He devotes a significant portion of his practice to post-grant proceedings, particularly on software technologies, before the U.S. Patent and Trademark Office (USPTO), and has been involved in more than 40 post-grant proceedings in the last three years alone.  His practice encompasses a range of technical areas, including software, medical devices, industrial equipment, and electronics.

Mr. May was a partner in the firm's European office from 2006 to 2011. While in Europe, he gained substantial experience in advising European high-tech companies on U.S. patent matters. He currently manages the U.S. patent portfolios for a number of European clients in various electrical and mechanical technologies. He is also a frequent lecturer on U.S. patent law and has spoken at numerous conferences in Europe.

Before joining the firm, Mr. May worked at the USPTO, where he examined patent applications relating to digital communications and image analysis, where he regularly dealt with software and patentable subject matter issues.

Philip Cupitt


Philip Cupitt, Ph.D. is a European patent attorney and partner at Finnegan Europe LLP - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP’s London office. He focuses his European practice on drafting and prosecuting patent applications across the full spectrum of engineering disciplines. His technical experience includes electronics, telecommunications, medical devices, optics, mechanical engineering, and manufacturing.

Dr. Cupitt has particular experience in obtaining patents for software. He has prosecuted hundreds of European patent applications for software-based inventions on behalf of U.S. companies, and he has helped UK companies to patent their software around the world. Dr. Cupitt is often asked to provide
pre-filing opinions on the patentability of software-based inventions under European law. He has a particular interest in database management systems, financial software, e-commerce, image and video processing, computer security, and Internet-based technologies.

Dr. Cupitt has extensive experience in opposition and appeal proceedings before the European Patent Office. His practice also includes freedom-to-operate investigations, opinions on patent infringement and validity, and preparing and prosecuting registered design applications.

Qinghong Xu

Lung Tin

Dr. Xu is a partner of Lung Tin International Intellectual Property Agent Ltd. (“Lung Tin”), where she focuses on all aspects of intellectual property matters, ranging from patent application preparation and prosecution, patent invalidation and litigation, to technology transfers, licenses, strategic alliances, R&D and commercialization collaborations. Dr. Xu also has advised clients on regulatory matters especially those before the Chinese State Food and Drug Administration. Dr. Xu joined Lung Tin in 2009.

 Prior to joining Lung Tin, Dr. Xu was a patent attorney with Goodwin Procter LLP (New York), practicing in the field of intellectual property law and focusing primarily on providing patent opinions and strategic patent counseling, and also on patent application preparation and prosecution, licensing and intellectual property litigation.
Before that, Dr. Xu was a patent agent with Fish & Richardson P.C. (Boston, New York) practicing included patent preparation and prosecution and patent counseling in the areas of medical, chemicals, pharmaceuticals, and biotechnology from 2000-2003.
Before her legal profession, she was a senior scientist at Orchid BioSciences, Inc. in Princeton, New Jersey, and C.H. Li Memorial Postdoctoral Fellow at the Rockefeller University in New York.

Andrew Spicer

director & senior patent counsel

Pravin Anand

managing partner
Anand & Anand

Pravin Anand, managing partner of the Firm, completed his law studies in New Delhi in 1979 and since then has been practicing as an Intellectual Property Lawyer.

He has been a counsel in several landmark IP cases involving the first Anton Piller Order (HMV cases); the first Mareva Injunction Order (Philips case); the first Norwich Pharmacal Order (Hollywood Cigarettes case); Moral rights of Artists (Amarnath Sehgal case); Recognition for Pro- Bono work for rural innovators at the grass root level' (National Innovation Foundation Award - Govt. of India); First order under the Hague
Convention (Astra Zeneca case) and several significant cases for pharma clients such as Novartis, Pfizer and Roche.

David Barron

Wragge Lawrence Graham & Co.

David has more than twenty years experience of patent litigation including conducting and co-coordinating litigation in multiple jurisdictions.

As head of the IP team's High-Tech group, he has particular experience of patent litigation in the telecoms, electronics and software fields as well as in a wide range of other technical areas. David has experience of patent litigation at the very highest level, having led the Wragge team in the two largest patent cases ever heard in the UK, involving 31 and 35 patents respectively. He is particularly well-known for his expertise in the relationship between patents and technical standards.

David has been named as one of the Worlds Leading Patent Practitioners "the IP risk management expert does fine work on cross-border spats" (IAM 2014) and as an IP Star by Managing Intellectual Property.

Nick Cunningham

Wragge Lawrence Graham & Co.

Nick regularly attends the international IP Committee meetings of two principal telecoms standard-setting bodies – the European Telecommunications Standards Institute and the International Telecommunications Union – in a representative capacity. He regularly works on strategic issues in Europe concerning the licensing of standards-essential patents.

Nick has over 20 years legal experience. He is leading the firm’s IP team in developing its knowledge and readiness for the introduction of the European Unitary Patent.

Nick is also an accredited mediator, trained by the Centre for Dispute Resolution, and has been involved in many mediations – both on clients’ behalf and as a mediator.

Roberto Dini

founder and president

With more than 40 year of experience, Mr. Roberto Dini is one of the best known and appreciated Intellectual Property experts. He began his career with Indesit where he was Head of the Patent and Trademark Office.

In 1982 Mr. Dini founded Sisvel, which has soon become a world leader in managing Intellectual Property and maximizing the value of patent rights.
In 1987 Mr. Dini founded Metroconsult, an Intellectual Property consultancy firm with offices in Turin, Milan and Genoa, wherein he transferred the experience acquired from the industrial world, providing his clients with high-quality services “tailored” to the needs of each individual client.

Mr. Dini is a Member of the Italian Industrial Property Consultant Association, a registered Patent Attorney before the European Patent Office (EPO) and Trademark and Design attorney before the Office for Harmonization in the Internal Market (OHIM).
Mr. Dini is currently the president of LES (Licensing Executives Society) Italy.

Born in 1946, Roberto Dini has a degree in Electronic Engineering from the Polytechnic of Turin. He is fluent in English, French and has a good knowledge of German. During his experience with industrial companies he invented over 30 patents.

Otto Licks

managing partner
Licks Attorneys

Otto Licks, founder and managing partner at Licks Attorneys, has over 20 years' experience.  Acting both as an attorney and law professor, he has established a solid reputation as a trial and litigation specialist, advising clients in areas such as intellectual property and life sciences in cases involving industries related to telecommunications, medical devices and information technology - among many others.

Regularly working with clients to resolve matters involving data package exclusivity, regulatory compliance, international patent issues, unfair competition, misleading advertising and qui tam actions, Otto Licks has an international client roster and considerable experience when it comes to the correct interpretation and enforcement of the law, dealing with regulatory agencies and protecting clients' rights at all levels. He is an accomplished speaker in the United States, Europe, Asia and Latin America, and has published extensively in his areas of expertise.

Carlos Aboim

Licks Attorneys

Carlos Aboim has nearly 20 years' experience as a trial and appellate litigator before state and federal courts. Since 2002, his practice has been focusing on complex disputes and leading cases in intellectual property, unfair competition, competition law and regulatory compliance - mainly in the areas of life sciences and information technology. With substantial first-chair trial and appellate experience (in lawsuits relating to pharmaceutical, medical device, computer system, telecommunications, and so on) he also advises multinational clients in international IP disputes.

Having received an LL.M in Intellectual Property Law from The George Washington University, he worked as a fulltime intern for the Honorable Chief Judge Randall Rader, Circuit Judge, U.S. Court of Appeals for the Federal Circuit, from June 2010 to October 2010. Aboim is also a frequent speaker at events related to his areas of expertise and a member of the Special Commission on Federal Judiciary Matters of the Rio de Janeiro State Chapter of the Brazilian Bar Association (OAB-RJ).

André Venturini
Andre Venturini
Licks Attorneys

André Venturini has ten years’ experience working with patent prosecution and patent litigation. He began his career at Momsen, Leonardos & Cia, where he occupied the positions of patent specialist, patent coordinator and partner – his last position at the time when the company changed its name to Kasznar Leonardos.

Venturini has in-depth knowledge of drafting patent applications, and analysis of FTO, infringement and nullity. He has also worked as technical assistant on the very first disputes concerning software-implemented inventions in Brazil.

Natalia Gulyaeva

Hogan Lovells

Natalia Gulyaeva is recognized as a leading Russian IPMT specialist and is named in legal directories including Chambers Global as a highly recommended Russian IPMT practitioner who is "really on top of things". She was selected by her peers for inclusion in The Best Lawyers in Russia in the intellectual property field. Natalia joined the firm in 2000 and, since 2004, has headed Moscow Intellectual Property, Media and Technology (IPMT) practice. Natalia advises clients on all aspects of contentious and non-contentious work including IP dispute resolution, portfolio management and strategic counseling as well as TMT specific transactional work and regulatory advice. Natalia is admitted to represent clients before the Russian PTO, Chamber for Patent and Trademark Disputes, Russian IP Court and other Russian courts. Natalia is also a member of the Famous and Well-Known Marks Committee of the International Association of Trademarks (INTA), and Rhine International Association of Lawyers. Natalia is a co-author of the Russian section of ICLG Telecoms, Media and Internet Laws and Regulations 2014, as well as of the Russian Section of Domain Name Law and Practice: An International Handbook (Second edition, Oxford University Press).

David Por

Allen & Overy

David is an experienced litigator specialised in all areas of intellectual property. His practice concentrates primarily on complex and cross-border intellectual property disputes, with a particular focus on patent cases, in which he also advises on validity and freedom to operate issues. David has notably represented leading actors in the patent wars of the telecommunications sector, as well as numerous pharmaceutical companies in proceedings against generics.

David has become a specialist of the interplay between intellectual property and competition law, notably in the field of standardised technologies.

Joachim Feldges

Allen & Overy

Joachim has practised complex patent litigation for more than 27 years and across all technical fields, with a particular focus on pharmaceuticals and biotechnology. He has experience developing and implementing international patent litigation strategies in numerous European jurisdictions, including on the requirements arising from parallel patent litigation in the U.S. He represents clients in infringement and validity cases before all major patent courts and he has acted in arbitration proceedings on patent disputes as well as a mediator to settle such disputes.

Joachim regularly represents clients in opposition proceedings before the European Patent Office. In addition, he is involved in the preparatory work for setting up a Unified Patent Court in Europe.

Nick Wallin
Nick Wallin
Withers & Rogers

Nick Wallin is a patent attorney and head of the Electronics, Computing & Physics group at Withers & Rogers. He works in fields ranging from electrosurgery and medical imaging through to sensors for defence purposes or the oil and gas industry, predominantly for UK based direct clients. He is also an experienced patent litigator who has handled cases before the UK Court of Appeal, High Court and Intellectual Property Enterprise Court.

Ian Hiscock

Head of IP Policy and litigation
Novartis International

David Rosenberg
Vice President IP Policy

David Rosenberg is Vice President of IP Policy at GlaxoSmithKline.  He is qualified as an English solicitor.
David joined GlaxoWellcome in February 2000 after 12 years in the IP Group at Clifford Chance, where he undertook litigation and transactional work, much of it in the patent field.  The majority of his work in his last five years at Clifford Chance related to the pharmaceutical industry.

David has responsibility for managing the development of GSK's position on many IP policy issues. He represents GSK on various industry bodies and UK and European cross-industry organisations.  He chairs the IP Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA).  In this role he was closely involved in the enquiry into the pharmaceutical sector carried out by DG Competition of the European Commission, which concluded in 2009. 

David has also had a close involvement in discussions within the pharmaceutical industry, and with the UK Intellectual Property Office and the European Commission, relating to the creation of a unitary European Patent and Unified Patent Court.
David is a regular speaker and occasional author on these issues.  He has twice been named one of the "50 Most Influential People in IP" by Managing Intellectual Property.

David has a law degree from Exeter University.  Before qualifying as a solicitor he spent three years doing legal research and teaching in the UK and US. 

Julia Florence

Assistant General Counsel (Patents)

Julia joined GSK's patent group in 2001.  As part of a team advising GSK's respiratory franchise she has provided IP support for several new products.  She has a particular interest in SPCs and the growing body of case-law in this area. 

Julia has experience of EPO oppositions and appeals, as well as litigation within Europe, including Turkey, and the US.  Julia also has an interest in policy issues and is a member of the ABPI IP expert network.

Prior to joining GSK, Julia worked for several years in private practice, as well as for the former Glaxo, Wellcome and SmithKline Beecham patent departments.

Lead Sponsor


Adams & Adams     

Anand and Anand      Finnegan

Gun & Partners    Hogan Lovells

Licks Attorneys     Lung Tin 

  Trevisan & Cuonzo   Withers & Rogers

     Wragge Lawrence Graham & Co

Exhibition Sponsors

Morningside IP   Park IP

Singh & Singh      Valipat

Association Partner


Media Partner


More from the Managing IP blog


null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates

Most read articles